These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17902008)

  • 1. The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers.
    Carrão JL; Moreira LB; Fuchs FD
    Eur Arch Psychiatry Clin Neurosci; 2007 Oct; 257(7):383-8. PubMed ID: 17902008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of sertraline as a cessation aid for smokers with a history of major depression.
    Covey LS; Glassman AH; Stetner F; Rivelli S; Stage K
    Am J Psychiatry; 2002 Oct; 159(10):1731-7. PubMed ID: 12359680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression.
    Landén M; Björling G; Agren H; Fahlén T
    J Clin Psychiatry; 1998 Dec; 59(12):664-8. PubMed ID: 9921700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buspirone effect on tobacco withdrawal symptoms: a randomized placebo-controlled trial.
    Robinson MD; Pettice YL; Smith WA; Cederstrom EA; Sutherland DE; Davis H
    J Am Board Fam Pract; 1992; 5(1):1-9. PubMed ID: 1561909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
    Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
    J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial.
    Evins AE; Cather C; Pratt SA; Pachas GN; Hoeppner SS; Goff DC; Achtyes ED; Ayer D; Schoenfeld DA
    JAMA; 2014 Jan; 311(2):145-54. PubMed ID: 24399553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy.
    Saules KK; Schuh LM; Arfken CL; Reed K; Kilbey MM; Schuster CR
    Am J Addict; 2004; 13(5):438-46. PubMed ID: 15764422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation strategies to increase antidepressant efficacy.
    Shelton RC
    J Clin Psychiatry; 2007; 68 Suppl 10():18-22. PubMed ID: 17900205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive-behavioral therapy to promote smoking cessation among African American smokers: a randomized clinical trial.
    Webb MS; de Ybarra DR; Baker EA; Reis IM; Carey MP
    J Consult Clin Psychol; 2010 Feb; 78(1):24-33. PubMed ID: 20099947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of fluoxetine and buspirone for treatment-refractory depersonalization disorder.
    Abbas S; Chandra PS; Srivastava M
    J Clin Psychiatry; 1995 Oct; 56(10):484. PubMed ID: 7559376
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
    Gaynes BN; Farley JF; Dusetzina SB; Ellis AR; Hansen RA; Miller WC; Stürmer T
    Depress Anxiety; 2011 Nov; 28(11):989-98. PubMed ID: 21898717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic.
    West R; Hajek P; McNeill A
    Psychopharmacology (Berl); 1991; 104(1):91-6. PubMed ID: 1882007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers.
    Cinciripini PM; Lapitsky L; Seay S; Wallfisch A; Meyer WJ; van Vunakis H
    J Clin Psychopharmacol; 1995 Jun; 15(3):182-91. PubMed ID: 7635995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.
    Pettinati HM; Oslin DW; Kampman KM; Dundon WD; Xie H; Gallis TL; Dackis CA; O'Brien CP
    Am J Psychiatry; 2010 Jun; 167(6):668-75. PubMed ID: 20231324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Varenicline for Adolescent Smoking Cessation: A Randomized Clinical Trial.
    Gray KM; Baker NL; McClure EA; Tomko RL; Squeglia LM; Saladin ME; Carpenter MJ
    JAMA Pediatr; 2019 Dec; 173(12):1146-1153. PubMed ID: 31609433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of buspirone on withdrawal symptoms associated with smoking cessation.
    Hilleman DE; Mohiuddin SM; Del Core MG; Sketch MH
    Arch Intern Med; 1992 Feb; 152(2):350-2. PubMed ID: 1739365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buspirone as an antidote to SSRI-induced bruxism in 4 cases.
    Bostwick JM; Jaffee MS
    J Clin Psychiatry; 1999 Dec; 60(12):857-60. PubMed ID: 10665633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.
    Oliveto A; Poling J; Mancino MJ; Williams DK; Thostenson J; Pruzinsky R; Gonsai K; Sofuoglu M; Gonzalez G; Tripathi S; Kosten TR
    Addiction; 2012 Jan; 107(1):131-41. PubMed ID: 21707811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.